Nick Glover
2016
In 2016, Nick Glover earned a total compensation of $2.1M as President and Chief Executive Officer at ProNAi Therapeutics, a 124% increase compared to previous year.
Compensation breakdown
| Non-Equity Incentive Plan | $223,125 |
|---|---|
| Option Awards | $1,354,717 |
| Salary | $525,000 |
| Other | $17,802 |
| Total | $2,120,644 |
Glover received $1.4M in option awards, accounting for 64% of the total pay in 2016.
Glover also received $223.1K in non-equity incentive plan, $525K in salary and $17.8K in other compensation.
Rankings
In 2016, Nick Glover's compensation ranked 4,623rd out of 14,075 executives tracked by ExecPay. In other words, Glover earned more than 67.2% of executives.
| Classification | Ranking | Percentile |
|---|---|---|
All | 4,623 out of 14,075 | 67th |
Division Manufacturing | 1,640 out of 5,486 | 70th |
Major group Chemicals And Allied Products | 510 out of 1,900 | 73rd |
Industry group Drugs | 377 out of 1,543 | 76th |
Industry Pharmaceutical Preparations | 298 out of 1,173 | 75th |
Source: SEC filing on April 25, 2017.
Glover's colleagues
We found two more compensation records of executives who worked with Nick Glover at ProNAi Therapeutics in 2016.